Atkinsrealis Group Inc header image

Atkinsrealis Group Inc

ATRL

Equity

ISIN CA04764T1049 / Valor 135469111

Toronto Stock Exchange (2024-11-22)
CAD 75.51+0.91%

Atkinsrealis Group Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Atkinsrealis Group Inc. operates as a company whose business details and specific areas of expertise are not directly outlined in the provided source. However, it is implied that the company is subject to financial analysis and forecasting by third-party financial analysts, suggesting its involvement in activities that garner significant interest from the investment community. The mention of consensus estimates based on forecasts and predictions made by these analysts indicates that Atkinsrealis Group Inc. is likely active in sectors where financial performance and future results are closely monitored and speculated upon. The disclaimer regarding the accuracy and reliability of information, along with a note on forward-looking statements, suggests a business environment subject to uncertainties and market dynamics. Without direct input from the company on these forecasts, it is clear that Atkinsrealis Group Inc. operates in a manner where its financial or operational performance is a matter of public interest and analysis, though the specific nature of its services or products remains unspecified in the source.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (12.06.2024):

Revenue Growth

Atkinsrealis Group Inc reported a significant increase in revenue for the first quarter of 2023, with total revenues reaching $2,264 million. This marks a substantial improvement compared to the previous year, highlighting the company's strong performance across its various sectors.

Net Income

For the first quarter of 2023, Atkinsrealis Group Inc achieved a net income of $46 million attributable to shareholders. This figure represents a robust year-over-year growth, reflecting the company's effective cost management and operational efficiency.

Earnings Per Share

The diluted earnings per share (EPS) for Atkinsrealis Group Inc stood at $0.26 for the first quarter of 2023. This EPS performance indicates a positive trajectory in the company's profitability, benefiting shareholders.

Backlog Value

Atkinsrealis Group Inc reported a strong backlog of $15,594 million at the end of the first quarter of 2023. The substantial backlog underscores the company's solid future revenue streams and ongoing demand for its services.

Future Outlook

Looking ahead, Atkinsrealis Group Inc remains optimistic about its performance for the remainder of 2023. The company expects continued revenue growth and profitability, driven by strategic initiatives and a focus on high-value markets.

Summarized from source with an LLMView Source

Key figures

%1Y
%3Y
%5Y

Performance

27.6%1Y
27.6%3Y
27.6%5Y

Volatility

Market cap

9362 M

Market cap (USD)

Daily traded volume (Shares)

388,043

Daily traded volume (Shares)

1 day high/low

74.9 / 71.92

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

q.beyond AG
q.beyond AG q.beyond AG Valor: 1062813
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.14%EUR 0.73
Fastly Inc
Fastly Inc Fastly Inc Valor: 47567307
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
17.44%USD 7.61
Santhera Pharmaceuticals Holding Ltd.
Santhera Pharmaceuticals Holding Ltd. Santhera Pharmaceuticals Holding Ltd. Valor: 127602882
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.27%CHF 8.00
Amano KK
Amano KK Amano KK Valor: 761489
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.29%JPY 4,201.00
GREE KK
GREE KK GREE KK Valor: 4831105
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.95%JPY 425.00
KK Plus Alpha Consulting
KK Plus Alpha Consulting KK Plus Alpha Consulting Valor: 111846082
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.36%JPY 1,710.00
Nitto Kogyo KK
Nitto Kogyo KK Nitto Kogyo KK Valor: 764441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.24%JPY 2,919.00
Hana Microelectronics Public Co Ltd
Hana Microelectronics Public Co Ltd Hana Microelectronics Public Co Ltd Valor: 1828652
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.34%EUR 0.73
Trainline Plc
Trainline Plc Trainline Plc Valor: 48455453
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.05%GBP 4.05
RWS Holdings PLC
RWS Holdings PLC RWS Holdings PLC Valor: 26733276
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.56%GBP 1.43